A hair growth questionnaire for use in the evaluation of therapeutic effects in men

Journal of Dermatological Treatment

Volumn 9, Issue 3, 1998, Pages 181-186

  Barber, B L ^a,d   Kaufman, K D ^b,e   Kozloff, R C ^f   Girman, C J ^c   Guess, H A ^c  

^a Health Economic Statistics   (United States)

^b Clinical Research   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d Health Economic Statistics   (United States)

^e Clinical Research   (United States)

^f Kunitz and Associates Inc   (United States)

Author keywords

Androgenetic alopecia; Clinical trials; Male pattern baldness; Psychosocial; Questionnaire

Indexed keywords

FINASTERIDE; MINOXIDIL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HAIR; HAIR GROWTH; HUMAN; MALE; MALE TYPE ALOPECIA; OBSERVATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF CONCEPT; SOCIAL PSYCHOLOGY; TOPICAL DRUG ADMINISTRATION;

EID: 0031706237     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.3109/09546639809160551     Document Type: Article

References (18)

1. Norwood O, Male pattern baldness: classification and incidence. South Med J (1975) 68: 1359-65.
2. Van der Donk MA, Passchier J, Dutree-Meulenberg ROGM et al. Psychological characteristics of men with alopecia androgenetica and their modification. Int J Dermatol (1991) 30: 22-8.
3. Cash TF, Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol (1993) 29: 568-75.
4. Cash TF, The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol (1992) 26: 926-31.
5. Kaufman KD, Clinical studies on the effects of oral finasteride, a type II 5-α reductase inhibitor, on scalp hair in men with male pattern baldness. In: van Neste, Dominique and Randall, Valerie A (editors), Hair research for the next millennium. Proceedings of the first tricontinental meeting of the hair research societies. Elsevier: Amsterdam, 1996.
6. Guyatt GH, Bombardier C, Tugwell PX, Measuring disease-specific quality of life in clinical trials. Can Med Assoc J (1986) 134: 889-95.
7. Streiner DL, Norman GR, Health measurement scales: a practical guide to their development and use. Oxford University Press: Oxford, 1989.
8. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika (1951) 16: 297-334.
9. Stewart AL, Ware JE, Measuring functioning and well-being: the medical outcomes study approach. Duke University Press: Durham 1992, pp 81-5.
10. Deyo RA, Diehr P, Patrick DL, Reproducibility and health status measures: statistics and strategies for evaluation. Control Clin Trials (1991) 12: 142S-58S.
11. Lin LI, A concordance correlation coefficient to evaluate reproducibility. Biometrics (1989) 45: 255-68.
12. Tukey JW, Ciminera JL, Heyse JF, Testing the statistical certainty of a response to increasing doses of a drug. Biometrics (1985) 41: 295-301.
13. Wilson IB, Cleary PD, Linking clinical variables with health-related quality of life - a conceptual model of patient outcomes. JAMA (1995) 273: 59-65.
14. Girman CJ, Jacobsen SJ, Guess HA et al, Natural history of prostatism: relationship among symptoms, prostate volume, and peak urinary flow. J Urol (1995) 153: 1510-15.
15. Passchier J, van der Donk J, Dutree-Meulenberg ROGM et al, Psychological characteristics of men with alopecia androgenetica and effects of treatment with topical minoxidil: an exploratory study. Int J Dermatol (1988) 27: 441-6.
16. Ware JE Jr, SF-36 health survey manual and interpretation guide. The Health Institute, New England Medical Center, Boston, Glossary, p 3.
17. Stunkard AJ, Burt V, Obesity and body image. II. Age at onset of disturbances in the body image. Am J Psychiatry (1967) 123: 1443-7.
18. Stunkard AJ, Mendelson M, Obesity and body image. I. Characteristics of disturbances in the body image of some obese persons. Am J Psychiatry (1967) 123: 1296-1300.